2015
DOI: 10.1120/jacmp.v16i6.5642
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of dose differences between two versions of Acuros XB algorithm compared to Monte Carlo simulations — the effect on clinical patient treatment planning

Abstract: A commercialized implementation of linear Boltzmann transport equation solver, the Acuros XB algorithm (AXB), represents a class of most advanced type ‘c’ photon radiotherapy dose calculation algorithms. The purpose of the study was to quantify the effects of the modifications implemented in the more recent version 11 of the AXB (AXB11) compared to the first commercial implementation, version 10 of the AXB (AXB10), in various anatomical regions in clinical treatment planning. Both versions of the AXB were part… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
19
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 19 publications
(24 citation statements)
references
References 33 publications
4
19
1
Order By: Relevance
“…Most of these studies were based on former versions of Acuros (v10 or v11). For each new version, minor improvements are made to the algorithm . The findings of the former studies differ considerably, showing large discrepancies between Acuros and MC calculations for a number of cases.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Most of these studies were based on former versions of Acuros (v10 or v11). For each new version, minor improvements are made to the algorithm . The findings of the former studies differ considerably, showing large discrepancies between Acuros and MC calculations for a number of cases.…”
Section: Discussionmentioning
confidence: 99%
“…A comparison to MC for 10 patients treated at different anatomical regions and with different treatment techniques found GAI below 90% for the PTV in four of the patients. The low GAI values were found for brain, breast, lung, and vaginal cancer patients . Most of these studies were based on former versions of Acuros (v10 or v11).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations